BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/23/2026 8:21:09 AM | Browse: 0 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 113326
Country China
Received
2025-08-22 08:30
Peer-Review Started
2025-08-22 08:30
First Decision by Editorial Office Director
2025-09-16 09:48
Return for Revision
2025-09-16 09:48
Revised
2025-09-25 12:23
Publication Fee Transferred
Second Decision by Editor
2026-01-23 02:41
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-01-23 07:12
Articles in Press
2026-01-23 07:12
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-02-27 08:39
Publish the Manuscript Online
2026-03-23 08:21
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Endothelial metabolic reprogramming influences tumor immune microenvironment
Manuscript Source Invited Manuscript
All Author List Ming Chen and Zhi-Gang Chen
ORCID
Author(s) ORCID Number
Zhi-Gang Chen http://orcid.org/0000-0001-8903-7042
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81972598, 82273337
National Key R&D Program 2022YFA1105201
Corresponding Author Zhi-Gang Chen, Chief, MD, PhD, Professor, Department of Breast Surgery (Surgical Oncology), Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou 310000, Zhejiang Province, China. chenzhigang@zju.edu.cn
Key Words Tumor microenvironment; Tumor endothelial cells; Metabolic reprogramming; Immunosuppression; Immunotherapy
Core Tip In recent years, the tumor microenvironment (TME) has emerged as a critical target in cancer research due to its role in regulating tumor growth, metastasis and treatment response. Immune cells are core components of the TME, and the effects of tumor cell metabolic reprogramming on immune cells are well understood. However, research on the impact of metabolic reprogramming of tumor endothelial cells on the tumor immune microenvironment is limited. This review summarizes metabolic changes in endothelial cells within the TME and their effects on the tumor immune microenvironment. It also suggests combining anti-angiogenic therapy that targets endothelial metabolism with immunotherapy as a future treatment option.
Publish Date 2026-03-23 08:21
Citation

Chen M, Chen ZG. Endothelial metabolic reprogramming influences tumor immune microenvironment. World J Clin Oncol 2026; 17(3): 113326

URL https://www.wjgnet.com/2218-4333/full/v17/i3/113326.htm
DOI https://dx.doi.org/10.5306/wjco.v17.i3.113326
Full Article (PDF) WJCO-17-113326-with-cover.pdf
Manuscript File 113326_Auto_Edited_101202.docx
Answering Reviewers 113326-answering-reviewers.pdf
Audio Core Tip 113326-audio.mp3
Conflict-of-Interest Disclosure Form 113326-conflict-of-interest-statement.pdf
Copyright License Agreement 113326-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 113326-non-native-speakers.pdf
Peer-review Report 113326-peer-reviews.pdf
Scientific Misconduct Check 113326-scientific-misconduct-check.png
Scientific Editor Work List 113326-scientific-editor-work-list.pdf
CrossCheck Report 113326-crosscheck-report.pdf